{
  "events": [
    {
      "drug": "Ryoncil (remestemcel)",
      "indication": "Steroid-refractory acute graft versus host disease",
      "company": "Mesoblast Limited",
      "pdufa_date": "1.7.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Tabelecleucel (Tab-cel)",
      "indication": "Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease",
      "company": "Atara Biotherapeutics",
      "pdufa_date": "1.15.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Vimseltinib",
      "indication": "Tenosynovial giant cell tumor (TGCT)",
      "company": "Deciphera Pharmaceuticals",
      "pdufa_date": "2.17.2025\ufeff",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Ctexli (chenodiol)",
      "indication": "Cerebrotendinous xanthomatosis",
      "company": "Mirum Therapeutics",
      "pdufa_date": "2.21.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Mirdametinib",
      "indication": "Neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN)",
      "company": "Springworks Therapeutics",
      "pdufa_date": "2.28.2025\ufeff",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Encelto (revakinagene taroretcel-lwey)",
      "indication": "Macular telangiectasia type 2 (MacTel)",
      "company": "Neurotech Pharmaceuticals",
      "pdufa_date": "3.6.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Fabhalta (iptacopan)",
      "indication": "C3 glomerulopathy (C3G)",
      "company": "Novartis",
      "pdufa_date": "3.20.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Rivoceranib/Camrelizumab",
      "indication": "Unresectable or metastatic hepatocellular carcinoma",
      "company": "Elevar Therapeutics",
      "pdufa_date": "3.20.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Vutrisiran",
      "indication": "ATTR-CM",
      "company": "Alnylam Pharmaceuticals",
      "pdufa_date": "3.23.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Diazoxide choline (DCCR)",
      "indication": "Prader-Willi syndrome",
      "company": "Soleno Therapeutics",
      "pdufa_date": "3.27.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Fitusiran",
      "indication": "Hemophilia A or B",
      "company": "Sanofi",
      "pdufa_date": "3.28.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Vanrafia (atrasentan)",
      "indication": "IgA nephropathy",
      "company": "Novartis",
      "pdufa_date": "4.2.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Uplizna (inebilizumab)",
      "indication": "Immunoglobulin G4-related disease (IgG4-RD)",
      "company": "Amgen",
      "pdufa_date": "4.3.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Nivolumab plus ipilimumab",
      "indication": "Hepatocellular carcinoma (HCC)",
      "company": "Bristol Myers Squibb",
      "pdufa_date": "4.21.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Prademagene zamikeracel (pz-cel)",
      "indication": "Epidermolysis bullosa",
      "company": "Abeona Therapeutics",
      "pdufa_date": "4.29.2025\ufeff",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Elamipretide",
      "indication": "Barth syndrome",
      "company": "Stealth BioTherapeutics",
      "pdufa_date": "4.29.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Nipocalimab",
      "indication": "Generalized myasthenia gravis",
      "company": "Johnson & Johnson",
      "pdufa_date": "4.30.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Yutrepia (treprostinil)",
      "indication": "Pulmonary arterial hypertension",
      "company": "Liquidia Corporation",
      "pdufa_date": "5.24.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Welireg (belzutifan)",
      "indication": "Advanced pheochromocytoma and paraganglioma (PPGL)",
      "company": "Merck",
      "pdufa_date": "5.26.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Khindivi (hydrocortisone)",
      "indication": "Pediatric adrenal insufficiency",
      "company": "Eton Pharmaceuticals",
      "pdufa_date": "5.28.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Sebetralstat",
      "indication": "Hereditary angioedema",
      "company": "KalVista Pharmaceuticals",
      "pdufa_date": "6.17.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Andembry (garadacimab)",
      "indication": "Hereditary angioedema",
      "company": "CSL",
      "pdufa_date": "6.18.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Nitisinone",
      "indication": "Alkaptonuria",
      "company": "Cycle Pharmaceuticals",
      "pdufa_date": "6.19.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Dupixent",
      "indication": "Bullous Pemphigoid",
      "company": "Sanofi",
      "pdufa_date": "6.20.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Taletrectinib",
      "indication": "Advanced ROS1-positive non-small cell lung cancer",
      "company": "Nuvation Bio",
      "pdufa_date": "6.23.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Gamifant (emapalumab)",
      "indication": "Still's disease",
      "company": "Sobi",
      "pdufa_date": "6.28.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Gammagard Liquid ERC (immune globulin infusion)",
      "indication": "Primary immunodeficiencies",
      "company": "Takeda",
      "pdufa_date": "6.30.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Linvoseltamab",
      "indication": "Multiple myeloma",
      "company": "Regeneron Pharmaceuticals",
      "pdufa_date": "7.10.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Avatrombopag",
      "indication": "Immune thrombocytopenia",
      "company": "Sobi North America",
      "pdufa_date": "7.24.2025\ufeff",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "TransCon hGH",
      "indication": "Growth hormone deficiency",
      "company": "Ascendis Pharma",
      "pdufa_date": "7.27.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Empaveli (pegcetacoplan)",
      "indication": "C3G and primary IC-MPGN",
      "company": "Apellis Pharmaceuticals",
      "pdufa_date": "7.28.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Sepiapterin",
      "indication": "Phenylketonuria (PKU)",
      "company": "PTC Therapeutics",
      "pdufa_date": "7.29.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Odronextamab",
      "indication": "Follicular lymphoma",
      "company": "Regeneron Pharmaceuticals",
      "pdufa_date": "7.30.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Alhemo (concizumab)",
      "indication": "Hemophilia A or B without inhibitors",
      "company": "Novo Nordisk",
      "pdufa_date": "7.31.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "UX111",
      "indication": "Sanfilippo syndrome (MPS IIIA)",
      "company": "Ultragenyx",
      "pdufa_date": "8.18.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Dordaviprone",
      "indication": "H3 K27M-mutant diffuse glioma",
      "company": "Jazz Pharmaceuticals",
      "pdufa_date": "8.18.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Vatiquinone",
      "indication": "Friedreich's ataxia",
      "company": "PTC Therapeutics",
      "pdufa_date": "8.19.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Donidalorsen",
      "indication": "Hereditary Angioedema",
      "company": "Ionis Pharmaceuticals",
      "pdufa_date": "8.21.2025\ufeff",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "PRGN-2012 (zopapogene imadenovec)",
      "indication": "Recurrent respiratory papillomatosis (RRP)",
      "company": "Precigen",
      "pdufa_date": "8.27.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Filspari",
      "indication": "IgA nephropathy",
      "company": "Travere Therapeutics",
      "pdufa_date": "8.28.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Rilzabrutinib",
      "indication": "Immune thrombocytopenia",
      "company": "Sanofi",
      "pdufa_date": "8.29.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Deramiocel",
      "indication": "Duchenne muscular dystrophy",
      "company": "Capricor Therapeutics",
      "pdufa_date": "8.31.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Orladeyo (berotralstat)",
      "indication": "Hereditary angioedema (HAE)",
      "company": "BioCryst Pharmaceuticals",
      "pdufa_date": "9.12.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Apitegromab",
      "indication": "Spinal muscular atrophy",
      "company": "Scholar Rock",
      "pdufa_date": "9.22.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Paltusotine",
      "indication": "Acromegaly",
      "company": "Crinetics Pharmaceuticals",
      "pdufa_date": "9.25.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "CUTX-101 (Copper Histidinate)",
      "indication": "Menkes disease",
      "company": "Fortress Biotech",
      "pdufa_date": "9.30.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Epioxa (Epi-on)",
      "indication": "Keratoconus",
      "company": "Glaukos Corporation",
      "pdufa_date": "10.20.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Belantamab mafodotin",
      "indication": "Multiple myeloma",
      "company": "GSK",
      "pdufa_date": "10.23.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Revuforj (revumenib)",
      "indication": "mNPM1 acute myeloid leukemia",
      "company": "Syndax Pharmaceuticals",
      "pdufa_date": "10.25.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Plozasiran",
      "indication": "Familial chylomicronemia syndrome",
      "company": "Arrowhead Pharmaceuticals",
      "pdufa_date": "11.18.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Sibeprenlimab",
      "indication": "Immunoglobulin A nephropathy (IgAN)",
      "company": "Otsuka Pharmaceutical Co.",
      "pdufa_date": "11.28.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Ziftomenib",
      "indication": "Relapsed or refractory acute myeloid leukemia (AML) with an NPM1 mutation",
      "company": "Kura Oncology and Kyowa Kirin",
      "pdufa_date": "11.30.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Pyrukynd (mitapivat)",
      "indication": "Alpha- and beta-thalassemia",
      "company": "Agios Pharmaceuticals",
      "pdufa_date": "12.7.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Uplizna",
      "indication": "Myasthenia gravis",
      "company": "Amgen",
      "pdufa_date": "12.14.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Aficamten",
      "indication": "Obstructive hypertrophic cardiomyopathy (oHCM)",
      "company": "Cytokinetics",
      "pdufa_date": "12.26.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Relacorilant",
      "indication": "Cushing's syndrome",
      "company": "Corcept Therapeutics",
      "pdufa_date": "12.30.2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Troriluzole",
      "indication": "Spinocerebellar ataxia (SCA)",
      "company": "Biohaven",
      "pdufa_date": "Q4 2025",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Tividenofusp alfa",
      "indication": "Hunter syndrome (MPS II)",
      "company": "Denali Therapeutics",
      "pdufa_date": "1.5.2026",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Clemidsogene lanparvovec (RGX-121)",
      "indication": "Mucopolysaccharidosis II (MPS II)",
      "company": "REGENXBIO",
      "pdufa_date": "2.8.2026",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Tabelecleucel",
      "indication": "Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD)",
      "company": "Pierre Fabre Pharmaceuticals",
      "pdufa_date": "10.10.2026",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    },
    {
      "drug": "Inqovi (decitabine and cedazuridine) plus Venclexta (venetoclax)",
      "indication": "Acute myeloid leukemia",
      "company": "Taiho Oncology",
      "pdufa_date": "2.25.2026",
      "fda_date_no_pdufa": "",
      "source_url": "https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/"
    }
  ]
}